https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1512339/full
Frontiers | Efficacy of PARPi re-maintenance therapy for recurrent ovarian cancer
ObjectiveThe current clinical data regarding the re-administration of PARPi maintenance therapy in platinum sensitive recurrent ovarian cancer (PSROC) is lim...
efficacy ofre maintenancefrontiersparpi
https://www.spandidos-publications.com/10.3892/ijo.2022.5379/abstract
Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other...
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
does not